Valeant Pharmaceuticals Completes Sale Of Dendreon To Sanpower Group

Industry Reports
Typography

Valeant Pharmaceuticals International, Inc. announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the Sanpower Group, Co., Ltd. , for $819.9 million in cash.

Valeant will use net proceeds from the sale to permanently repay term loan debt under its Senior Credit Facility.

With the closing of this transaction, the Company reiterates its expectation to pay down $5 billion in debt from divestiture proceeds and free cash flow within 18 months of August 2016.

"We continue to deliver on our commitments to reduce debt and simplify our portfolio, while focusing resources on our core businesses," said Joseph C. Papa, chairman and CEO, Valeant. "The proceeds from this sale along with the recently announced sale of the iNova business move us closer to paying down $5 billion of debt from divestitures and free cash flow, and we are confident we will meet and potentially exceed this commitment."

The Company estimates that the expected revenue and Adjusted EBITDA (non-GAAP) from the Dendreon business in the second half of 2017 would have been approximately $170 million and $65 million, respectively.

Established in 1993, the Sanpower Group has become one of the largest, private conglomerates in China. Headquartered in Nanjing, it offers a global platform for its three primary sectors: Healthcare, Retail and Financial Services.

About Valeant 
Valeant Pharmaceuticals International, Inc. is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, gastrointestinal disorders, eye health, neurology and branded generics. More information about Valeant can be found at www.valeant.com.

Arthur Shannon
This email address is being protected from spambots. You need JavaScript enabled to view it.
514-856-3855
877-281-6642 

Elif McDonald
This email address is being protected from spambots. You need JavaScript enabled to view it.
514-856-3855 
877-281-6642 (toll free)

Media Contact:
Lainie Keller
This email address is being protected from spambots. You need JavaScript enabled to view it.
908-927-0617

Sign up via our free email subscription service to receive notifications when new information is available.
captcha 

Market Movers

Rogers Corporation

NYQ : ROG - 16 Oct, 4:02pm
139.53
+2.83 (+2.07%) After Hours:
Open 137.60 Mktcap 2.54B
High 139.74 52wk Hight 139.74
Low 137.05 52wk Low 51.98
Vol 86121 Avg Vol 120528
Eps 5.55 P/e 33.70
Currency: USD

Banco Santander, S.A. Sponsored

NYQ : SAN - 16 Oct, 4:04pm
6.52
-0.01 (-0.11%) After Hours:
Open 6.51 Mktcap 20.57B
High 6.53 52wk Hight 6.99
Low 6.47 52wk Low 4.36
Vol 3.84M Avg Vol 5.41M
Eps 0.49 P/e 11.99
Currency: USD

Merck & Company, Inc. (new)

NYQ : MRK - 16 Oct, 4:00pm
63.34
-0.05 (-0.08%) After Hours:
Open 63.49 Mktcap 172.75B
High 63.73 52wk Hight 66.80
Low 63.26 52wk Low 58.29
Vol 7.45M Avg Vol 7.72M
Eps 3.87 P/e 34.24
Currency: USD

Johnson & Johnson

NYQ : JNJ - 16 Oct, 4:00pm
136.12
-0.31 (-0.23%) After Hours:
Open 136.45 Mktcap 365.35B
High 137.26 52wk Hight 137.52
Low 135.54 52wk Low 109.32
Vol 5.12M Avg Vol 5.26M
Eps 7.18 P/e 22.88
Currency: USD

Pfizer, Inc.

NYQ : PFE - 16 Oct, 4:00pm
35.98
-0.36 (-0.99%) After Hours:
Open 36.35 Mktcap 59.45B
High 36.48 52wk Hight 36.60
Low 35.88 52wk Low 29.83
Vol 13.58M Avg Vol 17.16M
Eps 2.56 P/e 26.26
Currency: USD

Direxion Daily 10-Yr Treasury B

PCX : TYO - 16 Oct, 3:37pm
13.81
+0.06 (+0.44%) After Hours:
Open Mktcap
High 52wk Hight 16.29
Low 52wk Low 13.12
Vol 0 Avg Vol 3888
Eps P/e
Currency: USD